Oxford, UK - Vaccitech’s scientific founders at University of Oxford announce positive high-level results from an interim analysis of clinical trials of AZD1222 in the UK and Brazil. Phase 3 interim analysis including 131 Covid-19 cases indicates that the vaccine is...
Month: November 2020
Oxford coronavirus vaccine produces strong immune response in older adults
Vaccitech Ltd, a clinical-stage biopharmaceutical company developing vaccines and immunotherapies to treat and prevent infectious diseases and cancer, announces that the ChAdOx1 nCov-2019 coronavirus vaccine, developed by teams at the University of Oxford, has been...
Apprentice Laboratory Technician
Vaccitech is looking to employ an Apprentice Laboratory Technician to provide technical support for the day-to-day smooth operation of our vaccine research laboratory, as well completing training to become a fully qualified laboratory technician. This position will...